Annual report pursuant to Section 13 and 15(d)

Acquisitions (Details) - Schedule of asset acquisition

v3.23.1
Acquisitions (Details) - Schedule of asset acquisition
12 Months Ended
Dec. 31, 2022
USD ($)
Schedule Of Asset Acquisition Abstract  
2,700,000 shares of Pasithea common stock $ 3,402,000
Warrants to acquire 1,000,000 shares of common stock at exercise price of $1.88 522,358
Cash 1,000,000
Non-refundable payment for AlloMek transaction expenses 50,000
Pasithea transaction expenses 697,121
Total cost of asset acquisition $ 5,671,479